Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Lawsuit claims Ozempic, Mounjaro labels downplayed severity of gastroparesis A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging the manufacturers downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, such as gastroparesis and gastroenteritis
1994 Aug 13;309(6952):453-7
What does semaglutide do to your body, and why is it so effective
Pre-clinical and Phase 2 data suggest this translates into lipid-lowering, hepatic-fat-reducing, and energy-expenditure effects that tirzepatide, by design, lacks
It works by mimicking the hormone GLP-1 (Glucagon-like Peptide 1), which regulates blood sugar levels and slows down the digestion process
